Stock Price Quote

DISHMAN CARBOGEN AMCIS LTD.

NSE : DCALBSE : 540701ISIN CODE : INE385W01011Industry : Pharmaceuticals & DrugsHouse : Dishman Pharma
BSE194.2516.85 (+9.5 %)
PREV CLOSE ( ) 177.40
OPEN PRICE ( ) 178.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 74184
TODAY'S LOW / HIGH ( )175.20 202.00
52 WK LOW / HIGH ( )129 321.15
NSE194.2516.62 (+9.36 %)
PREV CLOSE( ) 177.63
OPEN PRICE ( ) 177.63
BID PRICE (QTY) 194.25 (27)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2958960
TODAY'S LOW / HIGH( ) 175.00 202.50
52 WK LOW / HIGH ( )128.5 321.95
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 2007
Management Info
- Chairman Arpit J Vyas - Managing Director
Registered Office

Address Dishman Corporate House,Iscon - Bopal Road,Ambli,
Ahmedabad,
Gujarat-380058

Phone 02717 420102 / 124

Email dishman@dishmangroup.com

Website www.dishmangroup.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

16Mar Allotment of Debentures
Inter alia, to consider and approve:- The Proposal Of Fund Raising By W..
16Mar Allotment of Equity Shares
Inter alia, to consider and approve:- The Proposal Of Fund Raising By W..
20Jan Dishman Carbogen Amcis raises Rs 50 cr
Dishman Carbogen Amcis has raised Rs 50 crore through the allotment of 5..
20Jan Dishman Carbogen Amcis informs about a
Dishman Carbogen Amcis has informed that Management Committee of Board o..
12Jan Dishman Carbogen Amcis informs about
Dishman Carbogen Amcis has submitted the confirmation certificate receiv..

Financials

in Millions
QTR Dec 25 ANNUAL 25
Net Profit-231.3-98.7000000000002
Gross Profit -350.7 -308.3
Operating Profit 361047.7
Net Sales 396.83998.4

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  27934.60 (1.52%)
M.Cap ( in Cr)59359.08
Pfizer (BSE)
peergroup  4939.05 (5.36%)
M.Cap ( in Cr)22595.03
Astrazeneca Pharma I (BSE)
peergroup  8488.45 (1.66%)
M.Cap ( in Cr)21221.13
Hester Biosciences (BSE)
peergroup  1834.05 (5.67%)
M.Cap ( in Cr)1560.20
Senores Pharmaceutic (BSE)
peergroup  1052.35 (10.22%)
M.Cap ( in Cr)4846.45

Shareholding Pattern

PROMOTERS 59.32%
NON-INSTITUTION 31.61%
MUTUAL FUNDS/UTI 1.06%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Dishman Carbogen Amcis Ltd.

Dishman Carbogen Amcis Ltd. was incorporated in the year 2007. Its today's share price is 194.25. Its current market capitalisation stands at Rs 3045.51 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3998.4 Cr and Total Income of Rs.4328.2 Cr. The company's management includes Shrima G Dave, Dhaval Shah, Margie S Parikh, Hemantkumar J Bhatt, Kulin N Shah, Arpit J Vyas, Deohooti J Vyas.

It is listed on the BSE with a BSE Code of 540701 , NSE with an NSE Symbol of DCAL and ISIN of INE385W01011. It's Registered office is at Dishman Corporate House,Iscon - Bopal Road,AmbliAhmedabad-380058, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Haribhakti & Co LLP, Kunte & Associates., TR Chadha & Co LLP, VD Shukla & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.